Skip to Content
Merck
  • Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.

Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.

Nature structural & molecular biology (2014-10-06)
Taha Shahid, Joanna Soroka, Eric Kong, Laurent Malivert, Michael J McIlwraith, Tillman Pape, Stephen C West, Xiaodong Zhang
ABSTRACT

Mutations in BRCA2 increase susceptibility to breast, ovarian and prostate cancers. The product of human BRCA2, BRCA2 protein, has a key role in the repair of DNA double-strand breaks and interstrand cross-links by RAD51-mediated homologous recombination. Here, we present a biochemical and structural characterization of full-length (3,418 amino acid) BRCA2, alone and in complex with RAD51. We show that BRCA2 facilitates nucleation of RAD51 filaments at multiple sites on single-stranded DNA. Three-dimensional EM reconstructions revealed that BRCA2 exists as a dimer and that two oppositely oriented sets of RAD51 molecules bind the dimer. Single-stranded DNA binds along the long axis of BRCA2, such that only one set of RAD51 monomers can form a productive complex with DNA and establish filament formation. Our data define the molecular mechanism by which this tumor suppressor facilitates RAD51-mediated homologous-recombinational repair.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-BRCA2 (Ab-1) Mouse mAb (2B), liquid, clone 2B, Calbiochem®
Sigma-Aldrich
ANTI-FLAG® M2 antibody, Mouse monoclonal, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)